Video

Dr. Parker on next steps with mpMRI in prostate cancer

Author(s):

Urology Times staff

William P. Parker, MD, shares his expectations for the future of multiparametric MRI (mpMRI) in prostate cancer and where micro-ultrasound may fit alongside mpMRI in the paradigm. Parker is a practicing urologist at The University of Kanas Health System and an assistant professor at the University of Kansas Medical Center.

Related Videos
Conceptual image for prostate cancer treatment | Image Credit: © Dr_Microbe - stock.adobe.com
Prostate cancer cells dividing | Image Credit: © PRB ARTS - stock.adobe.com
Prostate cancer cells dividing | Image Credit: © PRB ARTS - stock.adobe.com
David I. Lee, MD, FACS, answers a question during a video interview
Todd M. Morgan, MD, answers a question during a Zoom video interview
Related Content
Bridget Koontz, MD: 18F-flotufolastat demonstrates high detection rate in low PSA setting
October 10th 2024

Bridget Koontz, MD: 18F-flotufolastat demonstrates high detection rate in low PSA setting

Urology Times staff
"We found that as soon as we got to the range of biochemical recurrence-defined PSA—0.2 ng/mL and up—the detection rate was very high," says Bridget Koontz, MD, FASTRO.
Dr. Schuster highlights the FDA approval of imaging agent flotufolastat F 18 in prostate cancer
June 22nd 2023

Dr. Schuster highlights the FDA approval of imaging agent flotufolastat F 18 in prostate cancer

Urology Times staff
"We're excited that the FDA approval of this radiotracer gives us yet more tools at our disposal to diagnose prostate cancer in all its forms, from early to late in the disease process," says David M. Schuster, MD, FACR.
Senior doctor asking elderly patient questions | Image Credit: © rocketclips - stock.adobe.com
October 7th 2024

Wayne G. Brisbane, MD, discusses AI-assisted HIFU for prostate cancer

Urology Times staff
"I think it's a really nice synergy between the 2 technologies," says Wayne G. Brisbane, MD.
Dr. Bristol Whiles discusses her experience as a urology resident
July 25th 2022

Dr. Bristol Whiles discusses her experience as a urology resident

Kansas University Department of Urology
On this podcast, Bristol Whiles, MD, discusses her urology residency experience at the Kansas University School of Medicine Department of Urology.
Study to compare TLX250-CDx vs contrast-enhanced CT for recurrent ccRCC
October 4th 2024

Study to compare TLX250-CDx vs contrast-enhanced CT for recurrent ccRCC

Hannah Clarke
“We are pleased that a first patient has been imaged in the CA-NINE trial, which supports potential label expansion for TLX250-CDx into recurrent, metastatic disease,” says David N. Cade.
Collaboration aims to streamline prostate MRI interpretation, fusion biopsy guidance
September 25th 2024

Collaboration aims to streamline prostate MRI interpretation, fusion biopsy guidance

Hannah Clarke
With this integration, imaging data from the DeepHealth software can be readily imported to the Trinity 3D Ultrasound Platform for prostate fusion biopsy.
© 2024 MJH Life Sciences

All rights reserved.